Agilent Technologies, Inc. - Diagnostics and Genomics SureGuide Human CRISPRi - Drug/Kinase/Ph
The SureGuide Human CRISPRi - Drug/Kinase/Ph from Agilent Technologies is a predesigned CRISPR interference (CRISPRi) library targeting genes involved in drug metabolism, kinase activity, and phosphatase function in human cells. This library is designed for use in functional genomics studies, enabling researchers to perform gene knockdown experiments with high specificity and efficiency. The SureGuide CRISPRi libraries utilize optimized guide RNA sequences to repress gene expression, facilitating the identification of gene function and potential drug targets. The product is suitable for high-throughput screening and is supported by Agilent's SureGuide platform for CRISPR-based applications.